Why buy CellTech?
- 75g of pharmaceutical-grade dextrose in every serving to cause sufficient insulin spike for creatine storage
- Increased strength and muscle gain
- Increased glycogen storage and recovery
Creatine monohydrate has been shown to significantly improve strength, power, recovery time and lean body mass1,2,3. MuscleTech Research and DevelopmentTM believes that their new advanced creatine formula, CELL-TechTM, is superior to regular creatine monohydrate. CELL-TechTM provides 10 grams of HPLC-tested pure creatine monohydrate per serving. Afetr ingestion of creatine monohydrate, the human body experiences a 50% creatine receptor-cite downgrade, peaking after approximately 6 hours4. As a result, large doses of creatine (up to 10g) will need to be consumed over a short period of time to maximise cellular uptake.
The inclusion of 75 grams of pharmaceutical-grade Dextrose is the same dosage advocated by the World Health Organization (W.H.O.) for use by physicians to assess the efficiency of insulin production in potential diabetic patients5. Studies performed by the leading creatine researcher Dr. Paul Greenhaff, have shown that very large amounts of dextrose are needed to significantly increase muscle creatine concentration6. Smaller amounts of dextrose may not have the same effect. Sport nutrition experts and trainers alike realize that insulin is the most anabolic hormone in the body. Once stimulated, it drives carbohydrates, amino acids (protein) and creatine monohydrate into muscle cells. For this reason, MuscleTech Research and Development has added a powerful insulin potentiator called Alpha Lipoic Acid to the CELL-TechTM formula. MuscleTech researchers believe that alpha lipoic acid may significantly increase insulin sensitivity, thereby increasing creatine absorption7. Based on preliminary research results, alpha lipoic acid appears to boost the insulin-signalling pathway within the muscle cell8. MuscleTech Research and Development has also added Chromium picolinate, Potassium, Phosphates, Taurine, ascorbic acid and Magnesium to further potentiate the actions of insulin and muscle contraction9.
The birth of Osmotic Acceleration Technolgy, is based on aground breaking research study conducted at the University of Toronto. This study will not only change the way creatine monohydrate is consumed, but also how all post-workout drinks are created. This study demonstrated that by mixing a particular amount of water with a carbohydrate solution you can vastly increase the speed at which the carbohydrates10 (and potentially creatine) enter the bloodstream and subsequently the muscle tissue through the actions of insulin and GLUT-4 transporters. CELL-TechTM is the first creatine delivery system to take advantage of the manipulation of osmolality (concentration) to increase creatine absorption and glycogen storage which is essential for recovery and maximum cell volumization.
In developing Osmotic Acceleration Technology, MuscleTech Research and Development even considered the dissolving properties of creatine which is something few companies have even considered. MuscleTech Research and Development has established a targeted water dosing schedule that is individualized for each athlete’s particular body weight. To achieve even greater results from CELL-TechTM, athletes should contact our Research Department and obtain their individual water dosing schedule.
A portion of every dollar spent on MuscleTech supplements is allocated towards the funding of university research in an attempt to discover new and more effective ways to increase lean muscle mass and strength, reduce bodyfat and improve athletic performance
References
1. Birch, R., et al. Eur. J. Appl. Physiol. 69:268-270, 1994.
2. Earnest, C., et al. Acta Physiol. Scand. 153:207-209, 1995.
3. Balsom, P., et al. Acta Physiol. Scand. 154:303-310, 1995.
4. Loike, J., et al. Proc. Natl. Acad. Sci. USA. 85:807-811, 1998.
5. Stolk, R., et al. Diabetes Care 18:1045-1049, 1995.
6. Green, A. L., et al. Acta Physoil Scand. 158(2):195-202, 1996.
7. Passwater, R. New Canaan, CT: Keats Publishing Inc. 1996.
8. Estrada, D. E., et al. Diabetes 45(12):1798-1804. 1996.
9. Anderson R. A., J Am Coll Nutr. 16(5):404-410, 1997.
10. Slevenpiper, J., Vuksan, V., et al. Diabetes Care 21(5): 711-716, 1998. |
